Cite
Humoral Response after Two Doses of BNT162b2 mRNA Vaccine Has a Role in Predicting Response after Three Doses That Is Related to Plasma HIV Viremia and Nadir CD4+ Cell Count in HIV-Positive Patients
MLA
Monica Basso, et al. “Humoral Response after Two Doses of BNT162b2 MRNA Vaccine Has a Role in Predicting Response after Three Doses That Is Related to Plasma HIV Viremia and Nadir CD4+ Cell Count in HIV-Positive Patients.” Vaccines, vol. 11, no. 1, Dec. 2022, p. 82. EBSCOhost, https://doi.org/10.3390/vaccines11010082.
APA
Monica Basso, Nicole Pirola, Susanna Pascoli, Beatrice Bragato, Antonio Vinci, Marco Iannetta, Francesco Colombo, Nicholas Geremia, Luca Martignago, Maria Cristina Rossi, Ludovica Cipriani, Mario Giobbia, Pier Giorgio Scotton, & Saverio Giuseppe Parisi. (2022). Humoral Response after Two Doses of BNT162b2 mRNA Vaccine Has a Role in Predicting Response after Three Doses That Is Related to Plasma HIV Viremia and Nadir CD4+ Cell Count in HIV-Positive Patients. Vaccines, 11(1), 82. https://doi.org/10.3390/vaccines11010082
Chicago
Monica Basso, Nicole Pirola, Susanna Pascoli, Beatrice Bragato, Antonio Vinci, Marco Iannetta, Francesco Colombo, et al. 2022. “Humoral Response after Two Doses of BNT162b2 MRNA Vaccine Has a Role in Predicting Response after Three Doses That Is Related to Plasma HIV Viremia and Nadir CD4+ Cell Count in HIV-Positive Patients.” Vaccines 11 (1): 82. doi:10.3390/vaccines11010082.